Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population‐based cohort study

Summary Background Little is known about the consequences of intrauterine exposure to, and the post‐natal clearance of, vedolizumab. Aims To investigate the levels of vedolizumab in umbilical cord blood of newborns and rates of clearance after birth, as well as how these correlated with maternal dru...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2021-11, Vol.54 (10), p.1320-1329
Hauptverfasser:	Julsgaard, Mette, Baumgart, Daniel C., Baunwall, Simon M. D., Hansen, Mette M., Grosen, Anne, Bibby, Bo M., Uldbjerg, Niels, Kjeldsen, Jens, Sørensen, Heidi G., Larsen, Lone, Wildt, Signe, Weimers, Petra, Haderslev, Kent V., Vind, Ida, Svenningsen, Lise, Brynskov, Jørn, Lyhne, Søren, Vestergaard, Thea, Hvas, Christian L., Kelsen, Jens
Format:	Artikel
Sprache:	eng
Schlagworte:	Babies Birth Cohort analysis Congenital defects Cord blood Demography Infants Infections Inflammatory bowel diseases Intrauterine exposure Medical records Neonates Population studies Population-based studies Pregnancy Umbilical cord
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!